학술논문
Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis: Two-year interim results from the open-label extension of the randomized BE RADIANT phase 3b trial
Document Type
Article
Author
Source
In Journal of the American Academy of Dermatology September 2023 89(3):486-495
Subject
Language
ISSN
0190-9622